Management | Scientific Advisors | Directors |
Scientific Advisory Board
The Company has assembled a Scientific Advisory Board that enables it to access some of the brightest minds in the life sciences arena. Members of the Board, in addition to Drs. Anchin, Skinner and Weiss, include:
- Edward Wiesmeier, M.D., Recently retired Clinical Professor, Obstetrics & Gynecology, UCLA School of Medicine and Assistant Vice Chancellor, who serves as Chairperson of the Board.
- Mark E. Josephson, M.D., Chief of Cardiology at Beth Israel Deaconess Medical Center, a major patient care, research and teaching affiliate of Harvard Medical School and the author of Clinical Cardiac Electrophysiology, the fundamental textbook in the field.
- Hein J. J. Wellens, M.D. Professor and Chairman of the Department of Cardiology at Academisch Ziekenhuis Maastricht in Amsterdam, the Netherlands. He is a Director of the Interuniversity Cardiology Institute of the Netherlands and is a member of the Netherlands Academy of Arts and Sciences. He also has an appointment of visiting lecturer at Harvard Medical School.
- Richard M. Luceri, M.D., F.A.C.C., Recently retired Director, Interventional Arrhythmia Center Holy Cross Hospital, Fort Lauderdale FL as well as a clinical investigator in the MADIT II (MultiCenter Automatic Defibrillator Implantation Trial) and author SCDHeFT (Sudden Cardiac Death Heart Failure Trial).
- Ariel D. Soffer, M.D., F.A.C.C., Chief of Medicine at Hollywood Medical Center, Hollywood FL. President and C.E.O. of Florida Institute for Cardiovascular Care (Healthworx).
- Hank Lubin, M.D., a practicing physician with Hightstown Medical Associates, PA, (formerly affiliated with the University of Pennsylvania Health System) and currently a Clinical Associate Professor at The University of Pennsylvania School of Medicine.
- Jules T. Mitchel, M.B.A., Ph.D., the Founder of Target Health, Inc., a full-service contract research organization supporting all aspects of pharmaceutical drug and device development.
- Frank S. Caruso, Ph.D., the Founder of two successful start-up pharmaceutical companies (Algos Pharmaceutical Corporation and Roberts Pharmaceutical Corporation) has more than 30 years experience directing worldwide clinical/pharmacological research and biological evaluation programs involving licensing and drug development research planning.
- David Fertel, D.O., a Clinical Professor of Surgery at Michigan State University, as well as a practicing Board Certified Thoracic and Cardiovascular surgeon in Michigan.
- Edward F. Lundy, M.D., Ph.D. is Chief of Cardiothoracic Surgery at the Active International Cardiovascular Institute at Good Samaritan Hospital in Suffern, New York. In addition to his M.D. from the University of Michigan, Dr. Lundy also received a Ph.D. from that institution in Physiology with a primary focus on altered-state physiologies such as hibernation.